Evidence map›Paper›PMID 32792954›Full record

ArticleFrontiers in pharmacology2020

Kaempferol Protects Blood Vessels From Damage Induced by Oxidative Stress and Inflammation in Association With the Nrf2/HO-1 Signaling Pathway.

He Yao, Jingyu Sun, Jie Wei, Xin Zhang, Bing Chen, Yajun Lin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Pequi (Antioxidants (Basel, Switzerland) · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. SIRT1-Mediated Epigenetic Protective Mechanisms of Phytosome-EncapsulatedInternational journal of molecular sciences · 2025
    Article
  19. Article
  20. Kaempferol MitigatesPharmaceuticals (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

He YaoThe Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, China.
Jingyu SunThe Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, China.
Jie WeiThe Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, China.
Xin ZhangThe Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, China.
Bing ChenInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Yajun LinThe Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, China.
Beijing Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over recent years, an increasing number of studies have confirmed that the occurrence and development of vascular pathological changes are closely related to oxidative stress and the inflammatory response of the vascular endothelium. Kaempferol is the most common flavonoid compound found in fruits and vegetables. Our present research identified that kaempferol had the capability to protect the vascular endothelium in a mouse model of vascular injury and explored the specific mechanisms underlying these effects by investigating oxidative stress, the extent of cardiovascular injury, and inflammatory markers such as NF-κB, TNF-α, IL-6, and the Nrf2/HO-1 signaling pathway. Analysis showed that kaempferol reduced oxidative stress and inflammation mediated by H

Indexed as

inflammationkaempferolNrf2oxidative stressvascular injury

Identifiers

PMID32792954
PMCPMC7387620
OpenAlexW3044545038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.